证券代码：300708 证券简称：聚灿光电 公告编号：2025-046 聚灿光电科技股份有限公司 关于 2025 年限制性股票激励计划内幕信息知情人 买卖公司股票情况的自查报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 聚灿光电科技股份有限公司（以下简称"公司"或"本公司"）于 2025 年 6 月 于 <聚灿光电科技股份有限公司 ensp="ensp" 年限制性股票激励计划="年限制性股票激励计划" 草案="草 案"> 及其摘要 的议案》等相关议案，具体内容详见公司于 2025 年 6 月 17 日收盘后在巨潮资讯 网(http://www.cninfo.com.cn)刊登的相关公告。 根据《上市公司股权激励管理办法》（以下简称"《管理办法》"）《深圳证 券交易所创业板上市公司自律监管指南第 1 号——业务办理》（以下简称"《自 律监管指南》"）等法律、法规及规范性文件的要求，遵循上市公司《信息披露 管理制度》 公司针对 2025 年限制性股票激励计划（以下简称"激励计划"）采取了充分必要 的保密措施，同时对激励计划的内幕信息知情人做了必要登记，并对内 ...

Core Points - The company announced the first vesting results of the 2024 restricted stock incentive plan, with a total of 418,656 shares vested [1][10] - The shares for this vesting were sourced from the company's repurchase of its A-share common stock from the secondary market [9] Summary of Relevant Sections Decision-Making Process and Disclosure - On April 28, 2024, the company's board and supervisory board approved the draft of the 2024 restricted stock incentive plan and related proposals [2][3] - The plan was publicly disclosed on April 29, 2024, on the Shanghai Stock Exchange website [2] Vesting Details - The total number of shares granted was 1,046,640, with 418,656 shares vested, representing 40% of the granted shares [7] - The vesting included 180 individuals, with core technical personnel and other key employees being the main recipients [9] Stock Source and Structure Changes - The vested shares were sourced from the company's repurchased A-share common stock, meaning there was no change in the total share capital of the company [9] - The controlling shareholder's stake remained unchanged before and after the vesting [9] Verification and Registration - The company received a verification report from an accounting firm confirming the subscription funds for the vested shares, totaling approximately RMB 9.54 million [9][10] - The registration of the vested shares was completed on June 26, 2025, as confirmed by the China Securities Depository and Clearing Corporation [10]

Core Viewpoint - The company anticipates gradual improvement in performance in Q2 2025 and the second half of the year, following the end of inventory destocking by downstream customers in the home respiratory device component sector [3]. Group 1: Home Respiratory Devices and Cochlear Implants - The company's core business involves the development, manufacturing, and sales of home respiratory devices and cochlear implant components [3]. - In 2024, the company expects a return to normal growth rates for home respiratory device component orders, supported by the Malaysian base potentially avoiding tariff risks, which is expected to drive long-term revenue growth [3]. - Revenue from cochlear implant components is showing steady growth, and new product component revenues are rapidly increasing, indicating effective diversification in business segments [3]. - Due to the impact of the Spring Festival on Q1 2025, revenue growth has slowed compared to the full year of 2024, but performance is expected to improve gradually as order deliveries resume [3]. Group 2: Blood Glucose Management and Production Expansion - The company has made breakthroughs in core technologies such as precision molds and liquid silicone, focusing on products like disposable injection pens, continuous glucose monitoring (CGM) devices, and insulin patch pumps [4]. - Collaborations with global medical device leaders are ongoing in the fields of blood glucose management, IVD diagnostics, and cardiovascular devices [4]. - A fully automated production project for insulin injection pens developed for international clients has achieved large-scale production in 2024 [4]. - The company has completed the core R&D work for its self-designed "Beautiful Pen," which includes three major technology directions [4]. - The Malaysian production base has successfully completed the first two phases of capacity construction, with the third phase expected to be operational by the end of 2025 [4]. Group 3: Stock Incentive Plan - The company has announced a stock incentive plan for 2025, granting a total of 5 million shares to no more than 304 core employees, representing 1.23% of the total share capital [5]. - The performance assessment for the stock incentive plan is based on revenue or net profit for 2023, with target growth rates for 2025-2027 set at no less than 56.25%, 95.31%, and 144.14% respectively [5]. - The triggering growth rates for 2025-2027 are set at no less than 44.00%, 72.80%, and 107.36% respectively, reflecting the company's confidence in long-term growth [5].

登录新浪财经APP 搜索【信披】查看更多考评等级 经审议，监事会认为：鉴于公司2024年半年度以及2024年年度利润分配方案已实施完毕，公司董事会根 据2022年年度股东大会授权对2023年限制性股票激励计划的相关事项进行调整，审议程序合法合规，符 合《上市公司股权激励管理办法》等有关法律、法规、规范性文件和公司《2023年限制性股票激励计划 （草案）》的相关规定，不存在损害公司及全体股东利益的情形。因此，监事会同意本议案。 表决结果：同意3票，反对0票，弃权0票。 证券代码：688076 证券简称：诺泰生物 公告编号：2025-051 江苏诺泰澳赛诺生物制药股份有限公司 第四届监事会第二次会议决议公告 本公司监事会及全体监事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性依法承担法律责任。 江苏诺泰澳赛诺生物制药股份有限公司（以下简称"公司"）第四届监事会第二次会议于2025年6月26日 下午16:00以通讯会议方式召开，会议通知于2025年6月20日以电子邮件方式送达全体监事。本次会议应 出席监事3人，实际出席监事3人，会议由监事会主席殷新波先生主持。会议的召开 ...

Core Viewpoint - The company has announced the achievement of vesting conditions for the second category of restricted stock under its 2022 incentive plan, allowing for the vesting of 973,000 shares at an adjusted grant price of 25.24 yuan per share [1][17]. Summary by Sections 1. Overview of the 2022 Restricted Stock Incentive Plan - The company held a shareholder meeting on October 17, 2023, approving the incentive plan which includes two categories of restricted stock [2]. - The grant price for the second category of restricted stock is set at 26.61 yuan per share, with adjustments possible due to corporate actions [2][3]. 2. Vesting Arrangements - The vesting schedule for the first grant of the second category of restricted stock includes three vesting periods: 30% after 12 months, 40% after 24 months, and 30% after 36 months from the grant date [3][4]. - For the reserved grants, the vesting conditions are similar, with adjustments based on the timing of the grant [4]. 3. Performance Assessment Criteria - The performance assessment for vesting includes annual targets for revenue growth and net profit growth from 2022 to 2024 [5][20]. - Specific targets include a revenue growth rate of 10% for 2022, 20% for 2023, and 20% for 2024, with corresponding net profit growth rates [5][20]. 4. Approval Process - The company has followed a structured approval process, including board meetings and shareholder approvals, to implement the incentive plan [6][8][9]. - Legal opinions and independent assessments were obtained to ensure compliance with regulations [7][8]. 5. Current Vesting Status - As of the latest board meeting, 201 eligible participants have met the vesting conditions, with a total of 1,035,300 shares available for vesting [17][27]. - The breakdown includes 978,300 shares for the first grant and 57,000 shares for reserved grants [17][26]. 6. Financial Impact - The company will account for the fair value of the vested shares in accordance with accounting standards, impacting its financial statements [28].

Core Viewpoint - The report serves as an independent financial advisory opinion on the 2025 Restricted Stock Incentive Plan of Shanghai Jingfeng Mingyuan Semiconductor Co., Ltd, ensuring compliance with relevant laws and regulations while assessing the plan's feasibility and potential impact on the company's sustainable development and shareholder interests [1][2][3]. Summary by Sections Section 1: Introduction - The independent financial advisor, Shanghai Xinguang Yihe Enterprise Management Consulting Co., Ltd, has been commissioned to provide an advisory report on the 2025 Restricted Stock Incentive Plan for Shanghai Jingfeng Mingyuan Semiconductor Co., Ltd [1]. Section 2: Assumptions - The report is based on several assumptions, including the stability of current laws and regulations, the accuracy of information provided by the company, and the absence of unforeseen adverse factors [2][5]. Section 4: Main Content of the Incentive Plan - The incentive plan involves granting second-class restricted stocks sourced from either newly issued A-shares or repurchased A-shares from the secondary market [6][7]. - A total of 1.073375 million restricted stocks will be granted, representing approximately 1.22% of the company's total share capital of 88.048706 million shares [6][7]. - The plan's effective period is set for a maximum of 60 months, with specific vesting arrangements and a purchase price of 48.88 yuan per share [11][8]. Section 5: Independent Financial Advisor's Opinion - The advisor confirms that the incentive plan complies with relevant regulations and does not pose any significant risk to the company or its shareholders [19][20]. - The plan is deemed feasible in terms of operational procedures and aligns with the company's strategic goals [21]. Section 6: Financial Impact - The implementation of the incentive plan is expected to positively influence the company's sustainable operations and shareholder equity by motivating key personnel [25]. - The advisor emphasizes that the funding for the incentive plan will come from the participants' own resources, ensuring no financial assistance from the company [26]. Section 7: Performance Assessment - The performance assessment framework includes both company-wide and individual performance metrics, focusing on revenue and gross profit targets for the years 2025 to 2028 [15][18]. - The plan aims to align the interests of the company, shareholders, and key personnel, fostering a culture of accountability and performance [27].

Core Viewpoint - The legal opinion letter from Zhejiang Jingheng Law Firm confirms that Hangzhou Dihun Network Technology Co., Ltd. has complied with necessary legal procedures for the repurchase and cancellation of part of its restricted stock under the 2024 incentive plan [1][7][9]. Group 1: Approval and Authorization - On March 27, 2024, the company held its fourth board meeting, approving the 2024 restricted stock incentive plan and related proposals [3][4]. - On April 25, 2024, the company convened its annual shareholders' meeting, which also approved the incentive plan and authorized the board to handle matters related to the repurchase and cancellation of restricted stocks [4][5]. Group 2: Repurchase and Cancellation Details - The company plans to repurchase and cancel a total of 516,650 shares of restricted stock due to various reasons, including the departure of 4 individuals and performance-related failures of 19 individuals [5][6][9]. - The breakdown of the repurchased shares includes 69,500 shares from departed employees, 387,150 shares from those who did not meet performance criteria, and 60,000 shares from reserved grants [6][8]. Group 3: Compliance and Future Actions - The legal opinion asserts that the repurchase and cancellation process adheres to the relevant laws and regulations, including the Company Law and Securities Law [7][9]. - The company has established a dedicated securities account for the repurchase and plans to complete the cancellation by July 1, 2025, along with necessary capital reduction registration [9].

Core Viewpoint - The legal opinion letter from Kangda (Chengdu) Law Firm confirms that Shede Liquor Co., Ltd. is proceeding with the repurchase and cancellation of restricted stocks as per the 2022 incentive plan due to certain conditions being met by the incentive targets [2][4][6]. Group 1: Repurchase Reasons - The repurchase is triggered by the departure of incentive targets under specific conditions such as contract expiration, voluntary resignation, or performance-related dismissals [4][5]. - The company has determined that four incentive targets no longer qualify for the incentive program due to their departure, leading to the repurchase of their unvested restricted stocks [5][6]. Group 2: Repurchase Quantity and Price - The total number of restricted stocks to be repurchased is 363,562 shares, affecting 262 incentive targets [6][8]. - The repurchase price is set at 69.04 yuan per share, which is the same as the grant price established in the 2022 incentive plan [6][8]. Group 3: Approval Procedures - The company has followed the necessary approval procedures, including obtaining authorization from the shareholders' meeting and the board of directors for the repurchase [8][9]. - The supervisory board has reviewed and agreed that the repurchase aligns with relevant laws and regulations, ensuring it does not adversely affect the company's management stability or financial performance [8][9]. Group 4: Conclusion - The legal opinion concludes that the repurchase has obtained the required approvals and adheres to the relevant legal frameworks, including the Company Law and the Management Measures for Equity Incentives [9].

证券代码：603258 证券简称：电魂网络 公告编号：2025-021 杭州电魂网络科技股份有限公司 上的《关于回购注销 2024 年限制性股票激励计划部分限制性股票的公告》（公告编 号：2025-009）。 《关 于回购注销部分限制性股票通知债权人的公告》（公告编号：2025-010），至今公示 期已满 45 天，公示期间公司未收到任何债权人对此议案提出异议的情况，也未收 到任何公司债权人向公司提出清偿债务或者提供相应担保的要求。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ? 回购注销原因：回购股权激励限制性股票并注销 一、本次限制性股票回购注销的决策与信息披露 杭州电魂网络科技股份有限公司（以下简称"公司"）于 2025 年 4 月 24 日召 开第五届董事会第四次会议审议通过《关于回购注销 2024 年限制性股票激励计划部 分限制性股票的议案》。鉴于公司 2024 年限制性股票激励计划（以下简称"《激励 计划（草案）》"或"本激励计划"）首次授予的 4 名激励对象因离职不再具备激 励资格，公司 ...

Summary of the 2024 Restricted Stock Incentive Plan Announcement Core Viewpoint The announcement details the implementation and results of the first vesting period of the 2024 Restricted Stock Incentive Plan by Guangdong Ruide Intelligent Technology Co., Ltd, highlighting the approval of vesting conditions and the number of shares to be listed for trading. Group 1: Implementation Overview - The company held meetings on June 10, 2025, to approve the achievement of vesting conditions for the first vesting period of the 2024 Restricted Stock Incentive Plan [1][2] - The total number of restricted shares granted under the plan is 234.46 million shares, with 847,145 shares eligible for vesting [11][15] - The vesting date for the shares is set for June 26, 2025, with an adjusted grant price of 9.21 yuan per share [11][19] Group 2: Vesting Conditions - The vesting conditions include company-level performance targets based on revenue growth, with a minimum growth rate of 15% for 2024 and 30% for 2025 [12][14] - Individual performance assessments will determine the vesting ratio for each participant, categorized into six performance levels [5][14] - A total of 161 participants will receive shares, while 470,955 shares will be forfeited due to non-fulfillment of conditions or participant departures [15][18] Group 3: Shareholder Impact and Compliance - The company will not experience a change in total share capital due to this vesting, as the shares are sourced from repurchased shares [19][20] - The legal opinion confirms that the vesting conditions have been met and comply with relevant regulations [20]